SquamousCellCarcinomaofSkin near Sarasota, FL

Care Philosophy: Dr. Fletcheris an Associate Professor of Medicine within the Division of Hematology and Oncology. He is a Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee.

Care Philosophy: As a cancer specialist with a very strong commitment to delivering the highest quality of care, I want to offer our patients convenient community access to a full range of the world's most advanced cancer treatments that provide the best possible outcomes and quality of life. For more information, visit www.floridacancercare.com

Care Philosophy: Dr Haider is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center and an Associate Professorof Oncologic Sciences at University of South Florida. Dr Haider received her Bachelor of Science as well as her Medical Degree at the University of Florida in Gainesville, FL. She completed an internship and residency in Internal Medicine at the University of Southern California in Los Angeles, CA followed by Hematology and Medical Oncology Fellowship at Moffitt Cancer Center - University of South Florida in Tampa, FL. Dr Haider's clinical practice is focused on neuroendocrine tumor (NET) oncology. As a member of the Endocrine Program Multidisciplinary team, she also treats paraganglioma and pheochromocytoma.

Care Philosophy: Dr Christine Sam is an Assistant Member in the Department of Individualized Cancer Management/Senior Adult Oncology Program. Dr Sam received her medical degree from Michigan State University College of Human Medicine in East Lansing. She completed an Internal Medicine Residency at University of Michigan Health Systems in Ann Arbor. She completed her Hematology and Medical Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine in Tampa. Dr Sam's primary clinical interest is the treatment of cancer in older patients and developing care plans tailored to their individual needs. Her focus is the treatment of breast, gastrointestinal, and genitourinary malignancies.

Biography: Dr. Richard Tuli, MD is a Radiation Oncology Specialist who practices in Tampa, FL. He is 50 years old. Dr. Richard Tuli, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Biography: Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. Fluent in English and Spanish, Dr. Sotomayor specializes in the treatment of lymphomas and leukemias. The accomplished physician-scientist's ongoing research is directed toward cancer immunology and immunotherapy with special focus in developing novel immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Considered as a world expert in mantle cell lymphoma (MCL), he has more than 140 publications including seminal discoveries published in top tier journals such as Nature Immunology, Nature Medicine, Blood, Proceedings of the National Academy of Sciences, Cancer Cell among others. He has been the recipient of several awards, including the recipient of the National Cancer Institute (NCI) CURE Lifetime Achievement award in 2017. Dr. Sotomayor is involved in several major medical societies and organizations and currently is a member of the Scientific Advisory Board, Lymphoma Research Foundation, member of the Executive Committee of the Mantle Cell Lymphoma Consortium and member of several committees of the American Association for Cancer Research (AACR). He has also served in committees at the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI)